Condition

Sexually Transmitted Infections (STIs)

ClinicalTrials.gov condition label

Clinical trials7

Recruiting6

Common interventions11

Lead sponsors shown4

Clinical trials

7 shown

STI Testing to Enhance PrEP Use in PregnancyNCT06919614 · 2025-06-18

Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in ThailandNCT07509853 · 2025-05-01

Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation StudyNCT07512869 · 2025-02-17

Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in SpainNCT06860945 · 2025-01-01

Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEXNCT07505875 · 2024-05-01

The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)NCT07512856 · 2024-02-01

Cape Town Young Women's Health CoOpNCT02974998 · 2016-11-01

Common interventions

Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testingDIAGNOSTIC_TEST1 Development and refinement of harm reduction modelBEHAVIORAL1 No Intervention: Observational CohortOTHER1 Pleasuremeter-based sexual pleasure discussion integrated with harm reduction servicesBEHAVIORAL1 Pleasuremeter-guided qualitative interviewBEHAVIORAL1 Self-administered questionnaire assessmentBEHAVIORAL1 Semi-structured in-depth interviews (IDIs)BEHAVIORAL1 Standard HTCBEHAVIORAL1 Transgender-tailored Harm Reduction ServiceBEHAVIORAL1 Understanding of chemsex patterns, impacts, and service needs among transgender personsBEHAVIORAL1 Young Women's Health CoOp (YWHC)BEHAVIORAL1

Leading sponsors

Institute of HIV Research and Innovation Foundation, Thailand4 Botswana Harvard AIDS Institute Partnership1 Hospital Universitario de Valme1 RTI International1

Trial status mix

RECRUITING6

COMPLETED1

Phase mix

NA3

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.